Search for Terms or Answers
Tom Appleton, MD, PhD, is division head of rheumatology at St. Joseph’s Health Care London, and associate professor in the departments of medicine and physiology and pharmacology at Western University, in Ontario, Canada.
Dr. Appleton leads a translational biology research program investigating pathologic disease mechanisms in various forms of osteoarthritis and other rheumatic diseases.
We all know that osteoarthritis is the most common form of arthritis in the world, and that obesity is its most modifiable risk factor. What I really want to focus on is the role that GLP-! receptor agonists might be playing in our management of osteoarthritis. So why does this matter?
Read ArticleBy downloading this material, I acknowledge that it may be used only for personal use and personal education and that I will accredit RheumNow.com as the source and owner of this material. Commercial use or mass reproduction of this material without permission from RheumNow (info@rheumnow.com) is prohibited.
